An old convent and rooms for rent: Schools struggle to find affordable housing for staff
Home sales declined for the seventh month in a row in August as higher mortgage rates and stubbornly high prices pushed prospective buyers out of the market.
Sales of existing homes — which include single-family homes, townhomes, condominiums and co-ops — were down nearly 19.9% from a year ago and down 0.4% from July.
Home prices continued to climb during the month, although it was the lowest year-over-year increase since June 2020. The median home price was $389,500 in August, up 7.7% from a year ago, according to a report from the National Association of Realtors. That’s down from the record high of $413,800 in June. The price increase marks more than a decade of year-over-year monthly gains.
“The housing sector is the most sensitive to and experiences the most immediate impacts from the Federal Reserve’s interest rate policy changes,” said Lawrence Yun, NAR’s chief economist. “The softness in home sales reflects this year’s escalating mortgage rates.
This story is developing and will be updated.
Shuttle Pharmaceuticals Holdings Fall Continues; Stock Down 11%
Shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) continues to fall, as it slips over 11% on Wednesday morning. The stock has plunged over 81% since its debut on August 31.
SHPH is currently trading at $7.47, down $1.01 or 11.93%, on the Nasdaq. The stock opened its trading at $9.66 after closing Tuesday’s trading at $8.48. The stock has traded between $7.25 and $126.26 in the past 52-week period.
Shuttle Pharmaceuticals is a development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing its side effects.
On Tuesday, the company said it entered into an agreement with TCG GreenChem, Inc. to manufacture Ropidoxuridine, the company’s lead clinical sensitizer drug candidate, for use in formulating the drug product for testing in clinical trials of Ropidoxuridine and RT of cancers.
The company had priced its IPO of 1.2 million shares at $8.125 per unit for proceeds of $9.96 million.
Evaxion Biotech Stock Gains 50% After Enrolling First Patient On Phase 2B Clinical Trial Of EVX-01
Shares of Evaxion Biotech A/S (EVAX) are gaining over 50% on Wednesday morning after the company enrolled its first patient in the global phase 2b clinical trial of EVX-01.
EVAX is currently trading at $3.0198, up $0.9798 or 48.0294%, on the Nasdaq. The stock has traded between $1.5100 and $25.0400 in the 52-week period.
Evaxion Biotech announced it had enrolled its first patient in the global phase 2b clinical trial of EVX-01, the company’s personalized cancer therapy for the treatment of melanoma.
In the company’s first phase 2b clinical trial, Evaxion is evaluating the efficacy and safety of EVX-01 in adults with metastatic melanoma. The trial is being conducted globally at clinical sites across the US, Europe, and Australia in collaboration with Merck & Co., Inc., which is supplying the trial with its PD-1 inhibitor, Keytruda.
Evaxion Biotech, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections.
U.S. Reports 29% Decrease In Covid Cases In 2 Weeks
The number of Covid positive cases in the United States has fallen by 29 percent in the last fortnight, as per the New York Times’ latest data.
A 9 percent decrease in Covid casualties was recorded in the country during the same period.
With 520 additional deaths reported on Tuesday, the total number of people that have lost their lives due to coronavirus infection in the country has risen to 1,051,323, as per Johns Hopkins University’s latest data.
67,306 new infections on the same day took the total U.S. Covid cases to 95,390,557.
Michigan reported the most number of deaths – 150 – and the most cases – 10,062.
1,944 additional deaths were reported globally on Tuesday, taking the total number of people who have lost their lives due to the pandemic so far to 6,518,352.
93,460,171 people have so far recovered from the disease, the Worldometer tally shows.
U.S. hospitals reported a 10 percent decrease in the number of Covid patients in the last two weeks. The number of I.C.U. admissions due to the worse stage of the viral disease has also fallen by 8 percent.
U.S. Covid hospitalizations fell to 34,076. 4,133 of these patients are admitted in intensive care units.
The nation’s current test positivity rate is 12 percent.
WPP Group Acquires JeffreyGroup In Latin America For Undisclosed Terms
WPP Group Plc (WPP.L,WPPGY), a British mass media firm, announced Wednesday the acquisition of JeffreyGroup, one of the most respected independent corporate communications, public affairs, and marketing consulting firms in Latin America.
JeffreyGroup will join the Hill+Knowlton Strategies international network and will create the largest global communications agency presence in Latin America, doubling Hill+Knowlton Strategies’ footprint in the region.
Headquartered in Miami, with 330 people across offices in Mexico City, Brasilia, Rio de Janeiro, São Paulo and Buenos Aires, JeffreyGroup has been a powerhouse in Latin America for nearly three decades.
The agency specializes in developing innovative, award-winning brand and corporate communications programmes and public affairs strategies for clients across a broad range of industries, including Amazon, American Airlines, AstraZeneca, Bacardí, Bayer, BlackRock, Johnson & Johnson, Marriott International, Salesforce, TikTok, and Walt Disney World Resorts.